Prostate cancer antigen 3: Diagnostic outcomes in men presenting with urinary prostate cancer antigen 3 scores ≥100

Urology

Volumn 83, Issue 3, 2014, Pages 613-616

  Schröder, Fritz H ^a   Venderbos, Lionne D F ^a   Van Den Bergh, Roderick C N ^a   Hessels, Daphne ^b   Van Leenders, Geert J L H ^a   Van Leeuwen, Pim J ^a   Wolters, Tineke ^a   Barentsz, Jelle O ^b   Roobol, Monique J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE CANCER ANTIGEN 3; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SCORING SYSTEM;

AGED; ANTIGENS, NEOPLASM; BIOPSY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896867550     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.12.005     Document Type: Article

References (15)

1. M. Auprich, A. Bjartell, and F.K. Chun et al. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer Eur Urol 60 2011 Nov 1045 1054
2. D. Hessels, and J.A. Schalken The use of PCA3 in the diagnosis of prostate cancer Nat Rev Urol 6 2009 May 255 261
3. D. Hessels, J.M. Klein Gunnewiek, and I. van Oort et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer Eur Urol 44 2003 Jul 8 15
4. A.K. Wu, A.C. Reese, and M.R. Cooperberg et al. Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer Prostatic Dis 15 2010 Mar 100 105
5. M.J. Roobol, F.H. Schröder, and P. van Leeuwen et al. Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test Eur Urol 58 2010 475 481
6. M.J. Roobol, F.H. Schröder, and G.L.J.H. van Leenders et al. Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥100) Eur Urol 58 2010 893 899
7. J.O. Barentsz, J. Richenberg, R. Clements European Society of Urogenital Radiology ESUR prostate MR guidelines 2012 Eur Radiol 22 2012 Apr 746 757
8. C.M. Hoeks, M.G. Schouten, and J.G. Bomers et al. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers Eur Urol 62 2012 Nov 902 909
9. O. Visser, S. Siesling, and J.A.A.M. van Dijck Incidence of cancer in The Netherlands 1999/2000. Eleventh report of The Netherlands Cancer Registry 2003 Vereniging van Integrale Kankercentra Utrecht
10. M.J. Roobol, W.J. Kirkels, and F.H. Schröder Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands) BJU Int 92 Suppl 2 2003 Dec 48 54
11. L. Klotz Active surveillance for prostate cancer: overview and update Curr Treat Options Oncol 14 2013 Mar 97 108
12. M.J. Bussemakers, A. van Bokhoven, and G.W. Verhaegh et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer Cancer Res 59 1999 5975 5979
13. Y. Versluis, R. Kranse, G. Jenster, and M. Roobol PCA3 Score Change over Time in a Prostate Cancer Screening Population 2012 AUA Atlanta abstractnr. 2239
14. T. Klatte, M. Waldert, and M. de Martino et al. Age-specific PCA3 score reference values for diagnosis of prostate cancer World J Urol 30 2012 Jun 405 410
15. S. De Luca, R. Passera, and A. Milillo et al. Histological chronic prostatitis and high-grade prostate intra-epithelial neoplasia do not influence urinary prostate cancer gene 3 score BJU Int 110 2012 Dec E778 E782